7分免疫学sci期刊推荐

来源：SCI期刊网 分类：SCI论文发表 时间：2023-12-01 10:33 热度：

摘 要：7分免疫学sci期刊推荐？ sci期刊属于学术水平比较高的刊物，选择期刊投稿是很关键的，7分指的是影响因子为6.5到7.5之间的刊物。位于sci2区比较多，投稿之前要根据论文的内容，选择符合的刊

　　7分免疫学sci期刊推荐？sci期刊属于学术水平比较高的刊物，选择期刊投稿是很关键的，7分指的是影响因子为6.5到7.5之间的刊物。位于sci2区比较多，投稿之前要根据论文的内容，选择符合的刊物投稿。接下来，详细的推荐几本期刊，仅供参考。

　　1、JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

　　影响因子：7.4

　　学科领域：

　　大类：医学

　　小类：免疫学

　　中科院分区：2区

　　期刊简介：The journal is an open access journal, committed to disseminating information on the latest trends and advances in microbiology, immunology, infectious diseases and parasitology. Articles on clinical or laboratory investigations of relevance to microbiology, immunology, infectious diseases, parasitology and other related fields that are of interest to the medical profession are eligible for consideration. Article types considered include perspectives, review articles, original articles, brief reports and correspondence.

　　该期刊是一本开放获取期刊，致力于传播有关微生物学、免疫学、传染病和寄生虫学的最新趋势和进展的信息。与微生物学、免疫学、传染病、寄生虫学和医学界感兴趣的其他相关领域相关的临床或实验室研究的文章有资格考虑。考虑的文章类型包括观点、评论文章、原创文章、简短报告和信件。

　　2、CURRENT OPINION IN IMMUNOLOGY

　　影响因子：7.4

　　学科领域：

　　大类：医学

　　小类：免疫学

　　中科院分区：2区

　　期刊简介：Current Opinion in Immunology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.

　　In Current Opinion in Immunology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.

　　《免疫学当前观点》旨在促进有科学依据的、跨学科的、多尺度的辩论和思想交流。它包含精美、简洁和及时的评论和意见，特别强调过去两年发表的文章。除了描述最近的趋势之外，还鼓励作者对所讨论的主题发表主观意见。在《免疫学最新观点》中，我们通过系统地提供以下内容来帮助读者： 1. 以清晰易读的形式表达专家对其领域当前进展的看法。2. 从大量原始出版物中对最有趣的论文进行评估，并由专家注释。

　　3、Frontiers in Immunology

　　影响因子：7.3

　　学科领域：

　　大类：医学

　　小类：免疫学

　　中科院分区：2区

　　期刊简介：Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. Field Chief Editor Luigi Daniele Notarangelo is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.

　　《免疫学前沿》是该领域的领先期刊，发表经过严格同行评审的基础、转化和临床免疫学研究。该领域的主编 Luigi Daniele Notarangelo 得到了由国际研究人员组成的杰出编辑委员会的支持。这本多学科的开放获取期刊处于向全球研究人员、学者、临床医生和公众传播和交流科学知识和有影响力的发现的前沿。

　　4、OncoImmunology

　　影响因子：7.2

　　学科领域：

　　大类：医学

　　小类：免疫学

　　中科院分区：2区

　　期刊简介：Tumor immunology deals with the natural or therapy-induced recognition of cancers, as well as with the intricate interplay between oncogenesis, inflammation and immunosurveillance. We now create a new, high-profile journal, OncoImmunology, that specifically deals with tumor immunology. Recent progress has allowed for the first clinical demonstration (and FDA approval) of anticancer immunotherapies. There is also an ever growing suspicion that - unexpectedly - many of the currently used chemotherapeutic agents depend in their efficacy on the active contribution of immune effectors. To use a drastic metaphor, oncologists who applied successful chemotherapeutic (or radiotherapeutic) regimens have taken advantage of the immune system's capacity to recognize tumor-specific or tumor-associated antigens and to control cancer (stem) cell growth, without being aware of the invisible helping hands. As a result, immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies. There is also a strong rationale in favor of combining conventional anticancer therapies with immunotherapies.

　　肿瘤免疫学研究自然或治疗诱导的癌症识别，以及肿瘤发生、炎症和免疫监视之间复杂的相互作用。我们现在创建了一本新的、备受瞩目的期刊《OncoImmunology》，专门研究肿瘤免疫学。最近的进展使得抗癌免疫疗法首次进行临床论证（并获得 FDA 批准）。人们越来越怀疑，出乎意料的是，目前使用的许多化疗药物的功效取决于免疫效应物的主动贡献。用一个激烈的比喻来说，应用成功的化疗（或放疗）方案的肿瘤学家利用了免疫系统识别肿瘤特异性或肿瘤相关抗原并控制癌细胞（干细胞）生长的能力，而没有意识到无形的因素。伸出援助之手。因此，免疫生物标志物对于确定癌症预后和预防癌症变得越来越重要。

文章名称：7分免疫学sci期刊推荐

文章地址：http://www.sciqk.com/lwgl/scilw/15055.html